Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16.5M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+6.17M
-
Total reported value, excl. options
-
$804M
-
Value change
-
+$200M
-
Put/Call ratio
-
0.96
-
Number of buys
-
72
-
Number of sells
-
-31
-
Price
-
$31.79
Significant Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q2 2021
139 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
.
Largest 10 shareholders include Column Group LLC (3.89M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.59M shares), PERCEPTIVE ADVISORS LLC (2.48M shares), BlackRock Inc. (1.61M shares), Ponoi Management, LLC (1.6M shares), WELLINGTON MANAGEMENT GROUP LLP (1.32M shares), KPCB XV Associates, LLC (1.3M shares), VANGUARD GROUP INC (914K shares), Alphabet Inc. (789K shares), and REGENTS OF THE UNIVERSITY OF CALIFORNIA (783K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.